VETOQUINOL Corporate brochure 2007 (year 2007)

Activity report 2007 / Outstanding events #05 Dec. 2007 Nephrology A European Academia seminar 90 practising veterinarians from 14 European countries considered the state of the art in renal pathology presented by the best international experts invited by Vétoquinol. On this occasion, the laboratory introduced its new product Rubenal ® , for treating fibrosis in chronic renal insufficiency in cats and dogs. January 2008 Feline herpes virus Launch of Enisyl ® -f After two years of successful marketing in the United States and Canada, Vétoquinol launched Enisyl ® -f in Europe, beginning with France. Enisyl ® -f is an innovative nutraceutical supplement, 100% natural, consisting of L-lysine in a palatable paste administered using a dial-a-dose syringe. FHV-1 is a highly contagious and sometimes severe disease affecting delicate animals. In cats with the disease, Enisyl ® -f helps to prevent disease- related infections, and also reduces the symptoms and their severity. February 2008 Cardio-nephrology Azodyl ® sets out to conquer Europe After the success of Azodyl ® in North America, Vétoquinol is extending its successful partnership with Kibow Biotech, Inc. to the international level. Azodyl ® is an innovative, patented product, 100% natural, consisting of (probiotic) bacteria, which reduces azotaemia in dogs and cats with renal insufficiency. Nov. 2007 Pain and inflammation Partnership in the United States Vétoquinol will distribute Vetprofen™ from GeoPharma in the United States. This nonsteroidal anti- inflammatory based on carprofen brings relief to dogs suffering from osteoarthritis or postoperative pain. This launch will help to raise Vétoquinol’s profile on the American market and adds to its growing range of products.